$9.65
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
KalVista Pharma (KALV) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestKalVista Pharma (NASDAQ:KALV) Stock Quotes, Forecast and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ:KALV) through any online brokerage.
Who are KalVista Pharma (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Inozyme Pharma (NASDAQ:INZY), Larimar Therapeutics (NASDAQ:LRMR), Sage Therapeutics (NASDAQ:SAGE) and Fate Therapeutics (NASDAQ:FATE).
What is the forecast, or price target, for KalVista Pharma (KALV) stock?
KalVista Pharma has a consensus price target of $26.00.
What is the current price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $9.65 last updated September 24, 2024 at 4:00 PM EDT.
Does KalVista Pharma (KALV) pay a dividend?
There are no upcoming dividends for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 5, 2024.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.